Cy5-TFSDLWKLL-OH

Rif. 3D-PC00002

Informazioni sul prodotto

• Nome: Cy5-TFSDLWKLL-OH
• Sinonimi: H-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-acid

Descrizione

Peptide Cy5-TFSDLWKLL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Cy5-TFSDLWKLL-OH include the following: In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor A Vaupel, P Holzer, S Ferretti, V Guagnano- Bioorganic & medicinal ..., 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960894X18307030 A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors R Wallbrecher, P Chène, S Ruetz- British Journal of ..., 2017 - Wiley Online Libraryhttps://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.13834 Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument P Furet , K Masuya, J Kallen, T Stachyra-Valat- Bioorganic & medicinal ..., 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960894X16308204 Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53-MDM2 interaction with a distinct binding mode F Gessier, J Kallen, E Jacoby, P Chene- Bioorganic & Medicinal ..., 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960894X15006514 Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction A Vaupel, G Bold, A De Pover, T Stachyra-Valat- Bioorganic & Medicinal ..., 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960894X14002662 Conformational biases of linear motifs EA Cino , WY Choy , M Karttunen - The Journal of Physical ..., 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jp407536p The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction P Furet , P Chène, A De Pover, TS Valat- Bioorganic & medicinal ..., 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960894X12004040 Local structural elements in the mostly unstructured transcriptional activation domain of human p53 H Lee , KH Mok , R Muhandiram, KH Park, JE Suk- Journal of Biological ..., 2000 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)79421-6/fulltext Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain PH Kussie, S Gorina, V Marechal , B Elenbaas- Science, 1996 - science.orghttps://www.science.org/doi/abs/10.1126/science.274.5289.948 NVP-CGM097 P Furet , K Masuya, J Kallen, T Stachyra-Valat, S Ruetz- sch900776inhibitor.comhttps://sch900776inhibitor.com/chrna9/nvp-cgm097/

• Marchio: Biosynth